MDA-supported scientists found raising SMN protein levels conferred significant benefits on young SMA mice, even after symptom onset

posted on August 4, 2011 - 9:40am
The "window of opportunity" for treating infants at risk of developing spinal muscular atrophy (SMA) may not be as narrow as some experts have feared, new experiments in mice suggest.

New content is being added every day. Please check back again.